Journal: Journal of dermatological science
Article Title: Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
doi: 10.1016/j.jdermsci.2015.12.009
Figure Lengend Snippet: Fig. 2. Treatment with calcipotriol and betamethasone dipropionate affects the activity of DCs resulting in a decreased secretion of TNF-a and IL-23. Monocytes (CD14+ cells)-derived DCs were cultured in presence of IL-4 and GM-CSF for 5 days and subsequently activated by co-stimulation with LPS and IFN-g for 3 days. Cells were treated in duplicates with 100 nM calcipotriol, 1 mM betamethasone (BDP), combination of calcipotriol and betamethasone (100 nM/1 mM; ratio 1:10 as in the fixed-combination product) or a corresponding vehicle control (0.1% DMSO). Treatment was applied after the first 5 days in culture and before and throughout the 3 days of activation with LPS and IFN-g (A) or two days after activation with LPS and IFN-g and throughout the last 24 h of activation (B). Protein levels of IL-23 and TNF-a were assessed by ELISA and MSD, respectively at the end of the 3 days of activation with LPS and IFN-g. The results expressed as the percentage difference compared to vehicle treatment control are mean values SEM from independent experiments using monocytes (CD14+ cells)-derived DCs from peripheral blood of four different healthy volunteers (n = 4). One-way ANOVA followed by Tukey’s multiple comparison tests were used to compare treatment effect. ****P 0.0001; ***P 0.001; **P 0.01; *P 0.05.
Article Snippet: After 48 h of treatment, cell culture supernatants were collected for protein analysis of IL-20 (Human IL-20 Quantikine) and IL-17C (Human IL-17C DuoSet) using ELISA kits from R&D Systems and of IL-8 and IL-6 using Human ProInflammatory-4 II Ultra-Sensitive Kit from Meso Scale Diagnostics.
Techniques: Activity Assay, Derivative Assay, Cell Culture, Control, Activation Assay, Enzyme-linked Immunosorbent Assay, Comparison